Prognostic significance of p53 immunoexpression in the survival of oral squamous cell carcinoma patients treated with surgery and neoadjuvant chemotherapy

Oncology Letters

Volumn 6, Issue 6, 2013, Pages 1611-1615

  Li, Li ^a,b   Fukumoto, Manabu ^b   Liu, Duo ^b,c  

^a GUANGDONG MEDICAL UNIVERSITY   (China)

^b TOHOKU UNIVERSITY   (Japan)

^c DALIAN UNIVERSITY   (China)

Author keywords

Oral squamous cell carcinoma; p53 immunohistochemical expression; Prognosis

Indexed keywords

CISPLATIN; FLUOROURACIL; PROTEIN P53;

ADJUVANT CHEMOTHERAPY; ADULT; AGED; ARTICLE; CANCER CLASSIFICATION; CANCER PROGNOSIS; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MOUTH SQUAMOUS CELL CARCINOMA; PROTEIN EXPRESSION;

EID: 84886789258     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2013.1627     Document Type: Article

References (30)

1. Jemal A, Siegel R, Ward E, et al: Cancer statistics, 2006. CA Cancer J Clin 56: 106-130, 2006.
2. Khuri FR, Lee JJ, Lippman SM, et al: Randomized phase III trial of low-dose isotretinoin for prevention of second primary tumors in stage I and II head and neck cancer patients. J Natl Cancer Inst 98: 441-450, 2006.
3. Gasparotto D and Maestro R: Molecular approaches to the staging of head and neck carcinomas (review). Int J Oncol 31: 175-180, 2007.
4. Shibata M, Kodani I, Osaki M, et al: Cyclo-oxygenase-1 and-2 expression in human oral mucosa, dysplasias and squamous cell carcinomas and their pathological significance. Oral Oncol 41: 304-312, 2005.
5. Kodani I, Shomori K, Osaki M, Kuratate I, Ryoke K and Ito H: Expression of minichromosome maintenance 2 (MCM2), Ki-67, and cell-cycle-related molecules, and apoptosis in the normal-dysplasia-carcinoma sequence of the oral mucosa. Pathobiology 69: 150-158, 2001.
6. Lumerman H, Freedman P and Kerpel S: Oral epithelial dysplasia and the development of invasive squamous cell carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 79: 321-329, 1995.
7. Silverman S Jr, Gorsky M and Lozada F: Oral leukoplakia and malignant transformation. A follow-up study of 257 patients. Cancer 53: 563-568, 1984.
8. Banoczy J and Csiba A: Occurrence of epithelial dysplasia in oral leukoplakia. Analysis and follow-up study of 12 cases. Oral Surg Oral Med Oral Pathol 42: 766-774, 1976.
9. Kalavrezos N and Bhandari R: Current trends and future perspectives in the surgical management of oral cancer. Oral Oncol 46: 429-432, 2010.
10. Guimaraes DP and Hainaut P: TP53: a key gene in human cancer. Biochimie 84: 83-93, 2002.
11. Oren M: Decision making by p53: life, death and cancer. Cell Death Differ 10: 431-442, 2003.
12. Gasco M and Crook T: The p53 network in head and neck cancer. Oral Oncol 39: 222-231, 2003.
13. Brosh R and Rotter V: When mutants gain new powers: news from the mutant p53 field. Nat Rev Cancer 9: 701-713, 2009.
14. Soussi T and Béroud C: Assessing TP53 status in human tumours to evaluate clinical outcome. Nat Rev Cancer 1: 233-240, 2001.
15. Perisanidis C, Perisanidis B, Wrba F, et al: Evaluation of immunohistochemical expression of p53, p21, p27, cyclin D1, and Ki67 in oral and oropharyngeal squamous cell carcinoma. J Oral Pathol Med 41: 40-46, 2012.
16. Coutinho-Camillo CM, Lourenco SV, Nishimoto IN, Kowalski LP and Soares FA: Nucleophosmin, p53, and Ki-67 expression patterns on an oral squamous cell carcinoma tissue microarray. Hum Pathol 41: 1079-1086, 2010.
17. Kato K, Kawashiri S, Tanaka A, et al: Predictive value of measuring p53 labeling index at the invasive front of oral squamous cell carcinomas. Pathol Oncol Res 14: 57-61, 2008.
18. Oliveira LR, Ribeiro-Silva A, Costa JP, Simões AL, Matteo MA and Zucoloto S: Prognostic factors and survival analysis in a sample of oral squamous cell carcinoma patients. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 106: 685-695, 2008.
19. International Union Against Cancer: TNM Classification of Malignant Tumours, Wiley-Liss, New York, NY, 2000.
20. Howaldt HP, Kainz M, Euler B and Vorast H: Proposal for modification of the TNM staging classification for cancer of the oral cavity. DOSAK. J Craniomaxillofac Surg 27: 275-288, 1999.
21. Kreppel M, Drebber U, Eich HT, et al: Combined-modality treatment in advanced oral squamous cell carcinoma: Primary surgery followed by adjuvant concomitant radiochemotherapy. Strahlenther Onkol 187: 555-560, 2011.
22. Kim SY, Nam SY, Choi SH, Cho KJ and Roh JL: Prognostic value of lymph node density in node-positive patients with oral squamous cell carcinoma. Ann Surg Oncol 18: 2310-2317, 2011.
23. Pillai KR, Sujathan K, Madhavan J and Abraham EK: Significance of silver-stained nucleolar organizer regions in early diagnosis and prognosis of oral squamous cell carcinoma: a multivariate analysis. In Vivo 19: 807-812, 2005.
24. Iype EM, Pandey M, Mathew A, Thomas G and Nair MK: Squamous cell cancer of the buccal mucosa in young adults. Br J Oral Maxillofac Surg 42: 185-189, 2004.
25. Girod SC, Krueger G and Pape HD: p53 and Ki 67 expression in preneoplastic and neoplastic lesions of the oral mucosa. Int J Oral Maxillofac Surg 22: 285-288, 1993.
26. Olivier M, Hainaut P and Borresen-Dale A: Prognostic and predictive value of TP53 mutations in human cancer. In: 25 Years of p53 Research. Hainaut P and Wiman K (eds). Springer, Dordrecht, the Netherlands, pp321-338, 2005.
27. Jäättelä M: Multiple cell death pathways as regulators of tumour initiation and progression. Oncogene 23: 2746-2756, 2004.
28. Igney FH and Krammer PH: Death and anti-death: tumour resistance to apoptosis. Nat Rev Cancer 2: 277-288, 2002.
29. Zheng H, Takahashi H, Murai Y, et al: Pathobiological characteristics of intestinal and diffuse-type gastric carcinoma in Japan: an immunostaining study on the tissue microarray. J Clin Pathol 60: 273-277, 2007.
30. Jackson JG, Pant V, Li Q, et al: p53-mediated senescence impairs the apoptotic response to chemotherapy and clinical outcome in breast cancer. Cancer Cell 21: 793-806, 2012.